Facebook
Twitter
LinkedIn
ForwardMidwest Pancreatic Cancer Scientific Symposium
Pancreatic cancer is increasing in incidence and will become the second leading cause of cancer-related deaths by 2020. Researchers have moved an important step closer to understanding why pancreatic cancer is so hard to treat. With a median survival of only 6 months and a 5-year survival rate of about 8%, patients tend to be diagnosed when the disease has already spread to other parts of the body -- this is one part of the problem. Another is that when treated with existing chemotherapy drugs, patients tend to benefit only slightly or not at all.
This is the first meeting concentrating on preclinical and translational research. The goal is to disseminate new scientific information while promoting collaboration between institutions that are performing research on pancreatic cancer.
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Medical College of Wisconsin designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Medical College of Wisconsin designates this activity for up to 6.75 hours of participation for continuing education for allied health professionals.
Please note: a $1.00 processing fee will be assessed for all registrations.
Target Audience
Surgeons
Research scientists
Learning Objectives
- Provide a current update on the genetic evolution of pancreatic cancer.
- Discuss evolving understanding of how Ras signaling affects the progression of pancreatic cancer
- Identify important immunologic targets in the tumor microenvironment
- Provide an update on current phase I clinical trials for pancreatic cancer
The conference will be held at the University Club of Chicago. The Palmer House Hilton (17 E Monroe St, Chicago, IL; (312) 726-7500) is convenient to the University Club and within walking distance to many of Chicago’s main attractions. A MCW group rate will be available until September 12th, 2017. Please contact the hotel directly to make a reservation
Speakers:
Steven Gallinger, MSc, MD, FRCSC
Professor of Surgery
Head, Division of HPB Surgical Oncology
Principal Investigator, Ontario Pancreas Cancer Study
University of Toronto
Steven Leach, MD
Professor of Surgery
Weill-Cornell Medical College
Director, David M. Rubenstein Center for Pancreatic
Cancer Research
Memorial Sloan Kettering Cancer Center
Marina Pasca di Magliano, PhD
Associate Professor of Surgery
University of Michigan Health Systems
Susan Tsai, MD, MHS (Activity Director)
Associate Professor of Surgery
Division of Surgical Oncology
Medical College of Wisconsin
Gwen Lomberk, PhD
Associate Professor of Surgery
Chief, Division of Research
Director, Basic Research in the Department of Surgery
Medical College of Wisconsin
Raul Urrutia, MD, MHS
Professor of Surgery
Director, Genomic Sciences and Precision Medicine Center
Medical College of Wisconsin
In accordance with the ACCMEⓇ standard for Commercial Support Number 6, all in control of content have NO relevant financial relationships to disclose with the exception of the following person(s):
Name | Company | Role |
Ralph Hruban, MD | Myriad Genetics miDiagnostics
| PalB2 discovery Board Member
|
Daniel Von Hoff, MD, FACP | Tolero | Consultant |
Michael Dwinell, PhD | Protein Foundry, LLC | Co-founder |
In accordance with the ACCME® standards for Commercial Support Number 6, these relationships were reviewed via the MCW conflict of interest resolution process and resolved.
Available Credit
- 6.75 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 6.75 Hours of ParticipationHours of Participation credit.